
This talk will provide an update on recent research advancements in acoustic neuroma, building on progress in tumour biology and clinical innovation. Dr. Yefet will explore evolving insights into vestibular schwannoma behaviour, including emerging approaches to identifying more aggressive tumours earlier in the disease course and the growing potential for individualized, precision-based treatment strategies. He will also discuss realistic next steps in research, including current limitations, anticipated timelines for clinical application, and the potential impact of these developments on future patient outcomes and care pathways.
Dr. Leo Yefet is a PhD candidate and neurosurgery resident at the University of Toronto whose work bridges artificial intelligence and neuro-oncology, with a focus on pediatric, adolescent, and young adult populations. His research integrates molecular profiling, plasma-based biomarkers, and advanced imaging analytics to develop non-invasive tools aimed at personalizing treatment across care settings.